JOYY, Inc. Sponsored ADR Class A (JOYY.US) achieved its highest year-over-year revenue growth rate in recent years in Q1, and plans to return $1.5 billion to shareholders over the next 3 years.
Gathering at Q1 revenue achieved the highest year-on-year growth rate in recent years.
On the morning of May 26th Beijing time, JOYY, Inc. Sponsored ADR Class A (JOYY.US) released its first quarter financial report for 2026. In this quarter, JOYY, Inc. Sponsored ADR Class A revenue reached $555.7 million, an increase of 12.4% year on year, marking the highest year-on-year growth rate in recent years. In this financial report, JOYY, Inc. Sponsored ADR Class A group disclosed performance according to three major business segments: social entertainment, advertising technology BIGO Ads, and e-commerce SHOPLINE, all of which achieved year-on-year growth.
The revenue from the social entertainment business, which serves as a strategic cornerstone, reached $400.4 million, an increase of 3.2% year on year, providing a stable cash flow foundation for the group. The advertising technology business BIGO Ads and e-commerce business SHOPLINE, which represent the second growth curve, both maintained strong growth momentum: BIGO Ads revenue reached $124.8 million, an increase of 55.6% year on year; SHOPLINE revenue reached $30.5 million, with a year-on-year growth rate of 16.1%.
In the first quarter of JOYY, Inc. Sponsored ADR Class A, non-GAAP operating profit and EBITDA reached $38 million and $45.7 million respectively, an increase of 22.5% and 13.2% year on year. The operating cash flow of JOYY, Inc. Sponsored ADR Class A reached $46 million this quarter; as of March 31st, the net cash reached $3.18 billion.
At the same time, JOYY, Inc. Sponsored ADR Class A group upgraded its shareholder return plan. During the period from 2026 to 2028, the group can repurchase $600 million worth of stocks and distribute $900 million in dividends, totaling up to $1.5 billion over 3 years.
Related Articles

SSY GROUP (02005): Sulfamethoxazole approved for registration as an active pharmaceutical ingredient for use in marketed preparations.

Metallurgical Corporation of China (01618) spent 1975.24 million yuan on May 25 to repurchase 7.0824 million shares of A-shares.

On May 22, BEKE-W (02423) invested 10 million US dollars to repurchase 1,829,600 shares.
SSY GROUP (02005): Sulfamethoxazole approved for registration as an active pharmaceutical ingredient for use in marketed preparations.

Metallurgical Corporation of China (01618) spent 1975.24 million yuan on May 25 to repurchase 7.0824 million shares of A-shares.

On May 22, BEKE-W (02423) invested 10 million US dollars to repurchase 1,829,600 shares.






